Acute blood-brain barrier permeabilization in rats after systemic Phoneutria nigriventer venom.
A highly controlled transport of substances at the interface between blood and brain characterizes the blood-brain barrier (BBB), fundamental for maintenance of the homeostasis of the cerebral milieu. In this study, we investigated the time course (15 min, 1, 2, and 5 h) of BBB opening induced by intravenous (i.v.) injection of Phoneutria nigriventer spider venom (PNV) using quantitative and morphological approaches on cerebellum and hippocampus vessels for assessment of BBB permeability. The results showed vasogenic edema and tracer extravasation faster and severalfold higher in hippocampus than in cerebellum. Reactive astrocytes with swollen perivascular end-feet processes were found only in cerebellum. An immediate and total degradation of laminin in capillaries occurred resulting in the disappearance of the basement membrane. In medium-sized vessels, this effect was less prominent. The changes were transient, with cerebellum in general presenting a faster recovery. However, at 5 h laminin was overexpressed, principally in hippocampus. The rapid and abrupt shift of laminin expression in capillaries (at 15 min) coincided with the immediate and severe signs of intoxication shown by the animals, but not with the peak of leakage of vessels and vasogenic edema, which occurred later (1-2 h). The findings suggest a complex regulatory mechanism, since the extension of BBB impairment caused by PNV depends on the region of the SNC, and on the vessels types. It is suggested that the components of the BBB (gliovascular unit) have a critical role in these differences. P. nigriventer venom can be a useful tool to explore the mechanisms of BBB.
Rapôso
Catarina
C
Departamento de Histologia e Embriologia, Instituto de Biologia, C.P. 6109, Universidade Estadual de Campinas, Campinas, SP, 13083-970, Brazil.
Zago
Gabriela Mariotoni
GM
da Silva
Gustavo Henrique
GH
da Cruz Höfling
Maria Alice
MA
D000818:Animals; D001485:Basement Membrane / Q000187:drug effects / Q000648:ultrastructure; D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000648:ultrastructure; D002199:Capillary Permeability / Q000187:drug effects*; D005455:Fluorescent Antibody Technique; D007797:Laminin / Q000187:drug effects / Q000378:metabolism; D008297:Male; D046529:Microscopy, Electron, Transmission; D009479:Neuropeptides / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D007797:Laminin; D009479:Neuropeptides; C064022:Tx1 neurotoxin